GC Corp.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy 2025-12-09 14:54
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.' 2025-12-08 14:36
GC Biopharma's Varicella Vaccine Strain 'MAV/06' Listed in WHO Position Paper 2025-12-02 13:00
GC Genome Publishes Blood-Based Colorectal Cancer Screening Study in the American Journal of Gastroenterology 2025-11-27 13:00
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, Demonstrates Safety and Immunogenicity in Phase 2 Data, Published in 'Vaccine' 2025-11-03 13:26
GC Biopharma Secures CMO Rights for Shingles Vaccine from Curevo Vaccine 2025-10-13 12:38
GCCL and Frontage Laboratories Announce Strategic Collaboration to Strengthen Global Clinical Trial Capabilities 2025-09-24 13:29
GC Biopharma Submits IND Application for Phase 1 Clinical Trial of COVID-19 mRNA Vaccine in Korea 2025-09-23 09:41
GC Biopharma's Study on Hunterase Lysosomal Delivery Mechanism Published in SCIE-Indexed Journal 2025-08-21 13:00
GC Biopharma Signs MOU with Thai Red Cross Society to Strengthen Collaboration on Plasma-Derived Therapies 2025-08-18 12:40
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam 2025-07-17 13:56
GC Biopharma's Phase 3 Clinical Trial Results for Hunterase Published in SCIE-Indexed Journal 2025-05-30 15:02
GC Biopharma Receives FDA Approval for its U.S. Plasma Collection Center in Calexico, California 2025-05-14 13:21
GC Biopharma Receives MFDS Approval for World's First Recombinant Anthrax Vaccine 2025-04-09 12:00
GC Biopharma Shares Research Updates on Rare Disorder Drugs at the WORLD Symposium 2025 2025-02-11 16:40
GCCL Wins 2025 Asia-Pacific Customer Value Leadership Award by Frost & Sullivan 2025-02-07 09:31
GC Biopharma and Novel Pharma First Patient Dosed in Global Phase I Clinical Trial for MPS IIIA Treatment 2024-11-26 08:44
GC Biopharma and Novelty Nobility Enter into Joint Research and Development Agreement for Geographic Atrophy Therapies 2024-10-29 09:13
GC Biopharma and Hanmi Pharmaceutical Receives IND Clearance for Phase 1/2 Clinical Trial from the U.S. FDA 2024-09-03 15:59
GCCL Completes Proactive Development of Biosimilar Clinical Trial Analysis Methods, Providing Customized Analysis Services through Enhanced R&D Capabilities 2024-07-17 10:38
1 2 3 4 5